2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. Enteropeptidase
  5. Enteropeptidase Inhibitor

Enteropeptidase Inhibitor

Enteropeptidase Inhibitors (5):

Cat. No. Product Name Effect Purity
  • HY-132841A
    Sucunamostat hydrochloride
    		Inhibitor 98.40%
    Sucunamostat (SCO-792) hydrochloride is an orally active and reversible enteropeptidase inhibitor with IC50s of 4.6 nM and 5.4 nM for rat enteropeptidase and human enteropeptidase, respectively. Sucunamostat hydrochloride can slowly dissociate from enteropeptidase in vitro and inhibit protein digestion in vivo.
  • HY-130126
    Sucunamostat hydrate
    		Inhibitor
    Sucunamostat hydrate (SCO-792) is an orally active and reversible enteropeptidase inhibitor with IC50s of 4.6 nM and 5.4 nM for rat enteropeptidase and human enteropeptidase, respectively. Sucunamostat hydrate can slowly dissociate from enteropeptidase in vitro and inhibit protein digestion in vivo.
  • HY-132841
    Sucunamostat
    		Inhibitor
    Sucunamostat (SCO-792 free acid) is an L-aspartic acid enteropeptidase inhibitor.
  • HY-147931
    Human enteropeptidase-IN-2
    		Inhibitor
    Human enteropeptidase-IN-2 (compound 1c) is a highly potent enteropeptidase inhibitor. Human enteropeptidase-IN-2 can be used for anti-obesity research.
  • HY-147927
    Human enteropeptidase-IN-1
    		Inhibitor
    Human enteropeptidase-IN-1 (compound 6b) is a highly potent, orally active and low systemic exposure enteropeptidase inhibitor. Human enteropeptidase-IN-1 boosts the increase in fecal protein output, and exhibits potent body weight loss in diet-induced obese (DIO) rat model. Human enteropeptidase-IN-1 can be used for anti-obesity research.